Shire
Takeda announces new UK MD, ahead of Shire transformation
May 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Takeda, appointment, pharma
“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …
Top Ten most popular articles on Pharmafile.com this week
April 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, FDA, Fresenius, Shire, Takeda, arthritis, pharma
The year seems like it’s running away as we come to the end of April. It’s been a more tense …
Takeda announce new UK MD, ahead of possible Shire transformation
April 26, 2018Medical Communications Shire, Takeda, biotech, drugs, pharma, pharmaceutical
“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …
$64bn Takeda-Shire mega merger inches closer to closing
April 25, 2018Research and Development, Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical
From March onwards, Takeda has been nudging a deal with Shire onwards through repeatedly improved offers, which has seen the …
The May 2018 issue of Pharmafocus is now live!
April 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, MSD, Pharmafocus, Shire, Takeda, flypharma, keytruda, mhealth, mobile health summit, opdivo, pharma, sugar tax
Just in time for the first good weather of the year, the May 2018 edition of Pharmafocus is available to …
Top Ten most popular articles on Pharmafile.com this week
April 20, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, EMA, GW Pharma, J&J, JJ, MHRA, Mylan, Novartis, Sanofi, Shire, Takeda, biotech, drugs, epipen, keytruda, pharma, pharmaceutical
It’s the end of another week and there’s really been one story that has dominated the headlines – Takeda’s potential …
Allergan out but Takeda sticks to guns on Shire
April 20, 2018Medical Communications, Sales and Marketing Allergan, Shire, Takeda, biotech, drugs, pharma, pharmaceutical
Allergan performed an odd about-turn after initially declaring its interest in pursuing a deal for Shire, before reneging on that …
Shire jettisons oncology unit for $2.4bn, unbalancing Takeda deal
April 16, 2018Sales and Marketing Servier, Shire, Takeda, biotech, drugs, oncology, pharma, pharmaceutical
Shire has announced that it has entered a definitive agreement for French drugmaker Servier to take on its oncology business. …
Top Ten most popular articles on Pharmafile.com this week
April 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Cancer, Humira, Mylan, Novartis, Shire, Takeda, Teva, acquisition, cystic fibrosis, hepatitis C, pharma, top ten
It’s Friday the 13th, but that doesn’t change a strong showing from the industry this week as it continued to …
Takeda move for Shire looks increasingly likely
April 6, 2018Medical Communications, Sales and Marketing Japan, Shire, Takeda, UK, biotech, drugs, pharma, pharmaceutical
Takeda’s surprise announcement, just last week, that it was weighing up a move for Shire had some analysts sceptical about …
Takeda moots Shire move but big questions remain
March 28, 2018Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical
Takeda is considering making a bold move for Shire, after announcing, as per UK regulations, that it may make an …
Top Ten most popular articles on Pharmafile.com this week
February 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Alzheimer's, AstraZeneca, Eylea, FDA, Microsoft, Regeneron, Shire, Tremfya, eurordis, multiple myeloma, rare disease
It’s the last Friday of February, and it’s time for another run-down of the most popular stories of the week. …
Shire, Microsoft and EURORDIS form rare disease alliance
February 20, 2018Manufacturing and Production, Research and Development Microsoft, Shire, eurordis, pharma, rare disease
Rare disease specialist pharma firm Shire, rare disease patient alliance EURORDIS and tech giant Microsoft have announced they have formed …
Shire scores European approval for Adynovi in haemophilia A
January 15, 2018Sales and Marketing Adynovi, Europe, European Commission, Shire, haemophilia, haemophilia a, pharma
Shire has revealed that the European Commission has approved Adynovi (antihaemophilic factor (recombinant), PEGylated) for on-demand and prophylactic use in …
Top Ten most popular articles on Pharmafile.com this week
January 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, HIV, J&J, JJ, Johnson & Johnson, Pfizer, Shire, Teva, Xarelto, patient reported outcomes
The Xmas break is now a distant memory as we move further into January, and with another Friday comes another …
Latest content
